Metropolis Healthcare Limited

NSE METROPOLIS.NS

Metropolis Healthcare Limited Revenue Per Share for the year ending March 31, 2024: USD 2.83

Metropolis Healthcare Limited Revenue Per Share is USD 2.83 for the year ending March 31, 2024, a 3.58% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Metropolis Healthcare Limited Revenue Per Share for the year ending March 31, 2023 was USD 2.73, a -13.71% change year over year.
  • Metropolis Healthcare Limited Revenue Per Share for the year ending March 31, 2022 was USD 3.16, a 18.13% change year over year.
  • Metropolis Healthcare Limited Revenue Per Share for the year ending March 31, 2021 was USD 2.68, a 18.35% change year over year.
  • Metropolis Healthcare Limited Revenue Per Share for the year ending March 31, 2020 was USD 2.26, a 3.26% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
NSE: METROPOLIS.NS

Metropolis Healthcare Limited

CEO Mr. Surendran Chemmenkotil
IPO Date April 15, 2019
Location India
Headquarters 250-D, Udyog Bhavan
Employees 4,313
Sector Health Care
Industries
Description

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

Similar companies

INDIAMART.NS

IndiaMART InterMESH Limited

USD 26.05

0.68%

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.39

-1.98%

ALKEM.NS

Alkem Laboratories Limited

USD 60.83

0.86%

NAVINFLUOR.NS

Navin Fluorine International Limited

USD 41.96

0.53%

THYROCARE.NS

Thyrocare Technologies Limited

USD 9.54

0.38%

StockViz Staff

January 15, 2025

Any question? Send us an email